Compounds and compositions as protein kinase inhibitors

Details for Australian Patent Application No. 2007317349 (hide)

Owner IRM LLC Novartis AG

Inventors Perez, Lawrence B.; Nabakka, Juliet; Manley, Paul W.; Wrona, Wojciech; Li, Xiaolin; Liu, Xiaodong; Breitenstein, Werner; Brooks, Clinton; Molteni, Valentina; Revesz, Laszlo; Chianelli, Donatella; Loren, Jon

Agent Davies Collison Cave

Pub. Number AU-B-2007317349

PCT Pub. Number WO2008/058037

Priority 60/864,378 03.11.06 US

Filing date 2 November 2007

Wipo publication date 15 May 2008

Acceptance publication date 20 October 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 33/06 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/058037 Priority application(s): WO2008/058037

20 October 2011 Application Accepted

  Published as AU-B-2007317349

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317365-Anhydrous lithium hydroxide and/or lithium hydroxide monohydrate dispersions and grease compositions made from same

2007317347-Alphavirus and alphavirus replicon particle formulations and methods